Form 8-K - Current report:
SEC Accession No. 0001193125-24-264187
Filing Date
2024-11-22
Accepted
2024-11-22 15:11:02
Documents
18
Period of Report
2024-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d914468d8k.htm   iXBRL 8-K 47989
2 EX-10.1 d914468dex101.htm EX-10.1 22697
3 EX-10.2 d914468dex102.htm EX-10.2 22704
4 EX-10.3 d914468dex103.htm EX-10.3 21712
5 EX-10.4 d914468dex104.htm EX-10.4 22182
  Complete submission text file 0001193125-24-264187.txt   331385

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241121.xsd EX-101.SCH 4471
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241121_def.xml EX-101.DEF 13889
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241121_lab.xml EX-101.LAB 23245
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241121_pre.xml EX-101.PRE 14858
21 EXTRACTED XBRL INSTANCE DOCUMENT d914468d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241489219
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)